Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Micro-metastatic dissemination of tumor cells can occur early in cancer progression.
• The fate of these early disseminated tumor cells (DTCs) and the mechanisms governing their survival or clearance are not fully understood.

Purpose of the Study:

• To investigate the immune mechanisms controlling the fate of early disseminated tumor cells (DTCs).
• To elucidate the role of CD8+ T-cells in preventing metastasis in different tumor models.

Main Methods:

• Comparison of metastasis development in 4T1 and EMT6 tumor models in immunocompetent mice.
• Assessment of DTC clearance and metastasis following surgical resection of primary tumors.
• Evaluation of tumor cell growth and metastasis in immunodeficient mice (athymic, Rag2-/-).
• Investigation of the effects of CD8+ T-cell depletion, G-CSF, and myeloid-derived suppressor cells (MDSCs) on metastasis.

Main Results:

• EMT6 tumor-bearing mice cleared DTCs, while 4T1 models developed overt metastasis.
• Surgical resection of EMT6 tumors prevented metastasis, and mice rejected subsequent IV-injected tumor cells.
• Tumor cells readily metastasized in immunodeficient mice or immunocompetent mice with CD8+ T-cell depletion.
• G-CSF or granulocytic-MDSCs from 4T1 mice induced metastasis in EMT6 mice by suppressing CD8+ T-cells.

Conclusions:

• Immune surveillance, mediated by CD8+ T-cells, plays a critical role in clearing early disseminated tumor cells and preventing metastasis.
• Tumor progression and metastasis can be influenced by factors that suppress CD8+ T-cell activity, such as G-CSF and MDSCs.
• Understanding these immune mechanisms provides insights into controlling cancer spread.